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Abstract 
Background: Saliva is a readily accessible biofluid that is important for the overall quality of life, functionally 
essential in the chewing, swallowing, tasting, regulation mouth flora and prevention of caries. The aim of this 
study is to assess the global metabolomic profile of saliva in healthy Malaysian adults. Methods: As a first step 
to determining and understanding the metabolomic profile of saliva in healthy Malaysian adults, we have col-
lected saliva samples of 50 adults and measured the salivary metabolite to establish a profiling metabolite data, 
Human Metabolome Database (HMDB). Metabolites concentrations of saliva in healthy subjects were meas-
ured by using 1H NMR spectroscopy. Results: The results showed there was no significant inter-individual vari-
ations of the key metabolites observed among the healthy Malaysian adults and there was no significant varia-
tion of the metabolites between female and male subjects. Conclusion: The metabolomic profile of saliva in 
healthy Malaysian adults could be used to establish the metabolomic database and used as a comparison for 
future study of the saliva of specific diseases. 
Introduction 
Metabolomics provide an analysis of changing 
metabolite levels in biological samples [1]. 
Metabolomics have been applied to a number 
of important areas, which include the discovery 
of biomarkers as well as mechanistic studies 
aimed at discovering metabolites or metabolic 
pathways that regulate cellular and physiologi-
cal processes [1]. For example, metabolomics 
has been applied to clinical conditions such as 
Crohn's Disease, Cancer, Genetic inborn errors 
of metabolism and cardiovascular studies [2-3]. 
"Genomics and proteomics tell you what might 
happen, but metabolomics tells you what actu-
ally did happen." Said Bill Lasley,University of 
California, Davis. Metabolomics is more sensi-
tive than genomics and proteomics as the 
metabolome measured is the final downstream 
product of transcription and translation, thus 
closest to the phenotype. The most important, 
saliva can be the sample for metabolomics 
study and has advantages over other biofluids 
such as blood and urine. Saliva collection is 
non-invasive and relatively fast compare to oth-
er biofluids collection [4-5]. 
""Correspondence to: Yoshinobu Shoji, Faculty of Dentis-
try, University Technology MARA Sg. Buloh Campus, 
Jalan Hospital, 47000 Sungai Buloh, Malaysia. 
E-mail: shoji@salam.uitm.edu.my 
Tel: +603-61266620, Faks: +603-61266103 
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Saliva is readily accessible complex biological 
fluid that is produced in, and secreted from the 
salivary glands. It consists of 99 % water with 
electrolytes, mucus, proteins, and small molec-
ular weight metabolites making up the rest of 
the components [6-8]. Unbiased global metabo-
lomic has rapidly enhanced disease characteri-
zation and biomarker discovery. Metabolites 
within a broad range of pathways contributed to 
the differentiation of healthy from diseased indi-
viduals, as well as between disease pheno-
types. Some salivary metabolites have been 
successfully identifies using 1H Nuclear Mag-
netic Resonance (1H NMR) [9], but to date 
chemometrics has not been applied to saliva 
metabolite datasets to find potential markers for 
disease [10]. Metabolite profiling of saliva re-
mains largely under-explored despite demon-
strated potential for biomarker detection in other 
biofluids such as urine and blood [11-13]. 
There is no metabolic database of healthy 
adult available in Malaysia. The aim of this 
study is to establish the metabolomics profile 
database of healthy Malaysian adults. With the 
database, we hope future researches can be 
done to identify new biomarker for early diagno-
sis of diseases with more specific to the Malay-
sia population. 
Materials and Methods 
Participants 
50 healthy individuals (30 female and 20 male), 
aged 12 to 64 (median age of 38 years) , were 
recruited in this study. Informed consents were 
obtained from patients according to the IMU 
RCEC guideline. A total of 5 ml of saliva collect-
ed for analysis and immediately kept in the -80 
degree freezer. The subjects have been 
screened by measuring the blood pressure, 
glucose level, Body Mass Index, questionnaire 
regarding to health condition, diet habit and 
medication. The screening process was carried 
out to ensure the healthy subjects were collect-
ed. 
Saliva samples preparation 
For acquisition of salivary NMR data, the frozen 
harvested saliva will be thawed, and spun at 
3000 rpm to remove particulate matter. All sali-
va samples were prepared with addition of deu-
terated phosphate buffer for biofluid pH stabili-
zation (pH 7.4). Additionally, sodium 3-
trimethylsilyl- (2,2,3,3-2H4) -1-propionate (TSP) 
was added to serve as an internal standard and 
the deuterated solvent served as a field fre-
quency lock, for the NMR spectrometer. Sodi-
um azide was added as preservative. 
1H NMR metabolomic profiling 
All samples was analysed using a Bruker 
Avance III NMR spectrometer operating at 500 
MHz 1H observation frequency using standard 1 
dimensional acquisition parameters at UiTM 
Malaysia. All resulting NMR spectra were phase 
- and baseline-corrected. The data were Fourier 
transformed, and spectra were referenced to 
the TSP signal at 0 ppm. The results were then 
referenced using Bruker Topspin (version 3.1, 
Bruker, Fallanden, Switzerland) software. 
Multivariate data analysis 
Characterisation of spectral modulations by ap-
plication of multivariate statistical data analysis 
was used to reduce complexity of these data 
and to facilitate visualisation of inherent pat-
terns within the data. Data was normalised and 
scaled prior to multivariate analysis. The multi-
variate statistical analysis such as principal 
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components analysis (PCA) were applied. The 
key metabolites were further validated statisti-
cally through permutations methods (with 
10000 resampling) to ensure reliability and re-
producibility of the results. 
Results 
A sample 1H NMR spectrum of unstimulated 
saliva from healthy Malaysian adults with sever-
al resonances identified is shown in Figure 1 
and 2. Resonance assignments were made 
using Bruker Topspin software. All results were 
phased and baselined corrected. We have iden-
tified a small number of key metabolites that 
were present as part of the human saliva 
metabolome of healthy Malaysian adults. The 
metabolites found were Proprionate, Acetate, 
Alanine, Lactic acid, Tyrosine, Phenylalanine 
and Formate as shown in Table 1. Spectra de-
rived from saliva of healthy Malaysian adults 
were dominated by Acetate and Propionate as 
shown in Table 1. 
There is no significant inter-individual variations 
of the key metabolites were observed among 
the healthy Malaysian adults. To determine dif-
ferences between male and female saliva, 20 
healthy female subjects and 5 healthy male 
subjects were recruited. PCA scores plot of 1H 
NMR spectra derived from saliva of healthy fe-
male and male control showed there was no 
significant variation of the metabolites between 
female and male, as shown in Figure 3. 
propionate acetate 
alanine 
Lactidacid 
propionate Tyrosine 
rv 
Amino acid 
Protein envelop 
\V AAA \>N^N/\J 
Figure 1: Median 1H NMR spectra derived from saliva of healthy controls (aliphatic region) 
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Figure 2: Median 1H NMR spectra derived from saliva of 25 samples (aromatic region) 
Compound 
Propionate 
I Acetate 
Alanine 
I Lactic acid 
I Tyrosine 
I Phenylalanine 
I Formate 
1H chemical shift (ppm) 
1.04,2.18 
1.92 
1.47 
1.32 
6.89,7.18 
7.32,7.37, 7.42 
8.45 
Table 1:1H NMR assignments for Human Saliva at 500MHz 
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Discussion 
In the present study, the use of human saliva 
samples for NMR-based metabolomics was 
evaluated. High-resolution 1H NMR spectra was 
obtained, and the major signals were clearly 
assigned consistent with earlier studies. Tech-
nical advances in NMR spectroscopy, it is now 
possible to identify and quantify hundreds of 
metabolites from many different types of biolog-
ical samples in relatively short orders [9]. How-
ever, the procedure from sample collection to 
analysis is sensitive. Cellular debris from both 
human and bacterial sources may contribute 
various metabolites, and products of bacterial 
metabolism may also be present. Steroids, 
some other hormones, and many drugs and 
antibodies can diffuse from serum into saliva 
[13]. Filtration of saliva samples using centri-
fuge provides an effective method of removing 
both proteins and particulate matter from saliva 
samples. Analysis of the sample will be easier 
when the protein is removed from the sample 
[13]. It also depends on the method of collec-
tion, food components may be directly observed 
during targeted profiling of saliva [14]. For ex-
ample, caffeine can be solutes already dis-
solved in the food, and rapidly dissolve into the 
saliva. All of these factors provide the important 
information for consideration when collecting 
saliva sample. The result only showed of 25 
samples out of the total of 50 samples collect-
ed, 20 females and 5 males. This smaller sam-
ple set might be potentially affecting the result. 
The reason for reduced sample set was mainly 
due to the inhomogeneities in its field of the 
samples, outliers with weird peak that may be 
due to sugar, food or underlying systemic dis-
ease. Some studies indicated that there are 
age-associated alterations in certain aspects of 
salivary gland function [15]. In this study, the 
samples recruited were from age range from 19 
to 64. Studies enclosing a larger number of 
subjects and specific age group are needed to 
minimize the potential confounders. 
The samples collected in this study were only 
from around the Klang valley area. Samples 
from other states should be covered in order to 
establish a database that can represent the 
healthy adults in Malaysia. There are few un-
known peaks needed to be further investigated. 
Some metabolites in the saliva that were previ-
ously identified in other studies such as Butyr-
ate, Choline, Ethanol, Glycine, Histidine and 
Pyruvate were not found in this study. This 
might be due to the small sample size and thus 
inadequate of some metabolite concentration to 
be quantified. In cases where quantitation was 
not reliable for a particular compound, concen-
trations were either not used (for generation of 
a model using multivariate statistics), or report-
ed as being less than 1 (JM. It is known that 
gender has an influence over urinary metabolite 
concentrations [11, 12]. To determine differ-
ences in salivary composition due to gender, 20 
females and 5 males was obtained and ana-
lysed using 1H NMR spectroscopy coupled with 
targeted profiling. Figure 3 revealed no signifi-
cant variation between male and female saliva 
metabolites. As compare to the study of 
Takeda et al. [9], the male subjects has higher 
in concentration of nearly all to metabolites 
compared to female subjects, included acetate, 
formate, glycine, lactate, methanol, propionate, 
propylene, glycol, pyruvate, succinate, and tau-
rine. The sample size was obviously imbalance, 
as 20 female samples versus 5 males samples 
only. Thus, a larger sample set is needed for 
further validation and future clinical application. 
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Figure 3: PCA scores plot of 1H NMR spectra derived from saliva of healthy controls. (Labelled according 
to gender, coloured according to age groups). Comparison of male and female saliva. 
Conclusion 
We can readily apply the metabolic profile to 
identify the key metabolites in saliva by using 
1H NMR, following sample preparation and fil-
tration to remove interfering protein and particu-
late matter to ease the analysis procedures. 
The median of the 25 samples show the peaks 
and key metabolites were identified, therefore 
these metabolomic profiles of saliva is potential 
for the future study of adults with the disease. 
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numbers should be given in brackets as follows: '[grant number xxxx]' 
• Multiple grant numbers should be separated by a comma as follows: '[grant numbers xxxx, yyyy]' 
• Agencies should be separated by a semi-colon (plus 'and' before the last funding agency) 
• Where individuals need to be specified for certain sources of funding the following text should be added 
after the relevant agency or grant number 'to [author initials]'. 
An example is given here: This work was supported by the National Institutes of Health [AA123456 to C.S., 
BB765432 to M.H.]; and the Alcohol & Education Research Council [hfygr667789].' 
Evaluation of manuscripts 
Submitted manuscripts are subject to peer review and are expected to meet standards of academic excellence. 
Peer-reviewers identities will remain anonymous to the authors. The Editor-in-Chiefs decision regarding publi-
cation is based on the recommendation of the reports of reviewers, which will, at the Editors' discretion, be 
transmitted to the authors. 
Authors may suggest the names and addresses of a few potential reviewers. The Editors and Associate Editors 
will be guided but not necessarily bound by these suggestions. 
Form and Style of Manuscript 
Manuscripts must be written in English. Manuscript documents should be formatted as follows: 
• They should be typed on A4 form (21 *29.7 cm or 21.6x28 cm) 
• Double spaced 
• 2.5 cm (1 inch) margins 
• Justify 
• Page numbers at the bottom of each page; centered or right-justified 
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• Avoid boldface, underlining, or italics in the manuscript 
Other formatting notes: 
• We do not publish Appendices. 
• Do not embed figures into the manuscript. They must be uploaded as separate files for each figure. 
Separate pages should be used for the following:(1) title page (s), (2) abstract, (3) text, (4) footnote(s) to the 
text, (5) references, (6) table(s), (7) legend(s) to figure(s), (8) declaration of Funding and Conflict of Inter-
est . The manuscripts should be arranged in the order indicated above and all pages should be numbered in 
succession except the figure(s), the title page being page 1. 
Indicate the appropriate location in the text of the tables, figures, and other subsidiary materials by marginal 
notes. Latin words should be italicized (for example: in vitro, i.e., etc., per se). Footnote(s) to the author's name 
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superscript lower case (a, b, etc.), and placed at the bottom of the table. Acknowledgement (if any) should ap-
pear after the main text, and before the References. It is advised that authors note any conflict of interest in this 
section. 
Organization of Manuscript 
A desirable plan for the organization of a Regular Paper is as follows: (1) TITLE (2) ABSTRACT, (3) INTRO-
DUCTION with no heading, (4) MATERIALS AND METHODS (5) RESULTS (6) DISCUSSION (7) REFER-
ENCES. 
1. Title Page 
Provide a title page, containing the following items. 
i) The type of paper 
ii) Title. The title should be informative and as short as is consistent with clarity. The title should not include 
chemical formulae or arbitrary abbreviations, but chemical symbols may be used to indicate the structures 
of isotopically labeled compounds. The numbering of parts in a series of papers is not permitted, but titles 
and subtitles may be used if necessary. 
iii) Next-line. List full names of all authors. A footnote reference(s) to an author(s), indicating a change of ad-
dress, should be given on the title-page. 
iv) Next-line. List the institution(s) in which the work was carried out, and the Zip Code / post code, if availa-
ble. 
v) Running title. Provide a short running title of less than 50 strokes. It should be as informative as possible. 
vi) The name, complete mailing address, telephone number, Fax number, and E mail address of the person to 
whom correspondence should be sent. To expedite the review, much of the journal's correspondence will 
be by E mail. 
vii) Abbreviations. Non-standard abbreviations should be defined, even if they are known to those familiar with 
the field. List all non-standard abbreviations used in the paper in alphabetical order in a footnote on the title 
page. 
Customary abbreviations in wide use need not be defined in text (e.g., RNA, ATP). Define other abbreviations 
the first time that they are used. Refer to the Journal of Biological Chemistry for recommended abbreviations for 
biological compounds, Chemical Abstracts for names of chemical compounds, Conn's Biological Stains (10th 
Edition, RW Horobin and JA Kiernan (eds.), BIOS Scientific Publishers) for nomenclature, and the CSE Style 
Manual (2006, 7th ed., Council of Science Editors) for scientific abbreviations. Use SI units only. The Journal 
does not print the degree symbol before temperature symbols. All temperatures are printed as follows: 80C, 
37.4F, 276K. 
2. Abstract 
i) The Abstract should nor exceeding 250 words. Abstract text should be divided into the following sections: 
Objectives (a brief statement of the purpose of the investigation along with the the working hypothesis)-
Materials and Methods (A brief description of the materials and experimental method used); Results 
(state the results simply and clearly so that significant facts can be readily identified, where appropriate, 
statistics should be clearly stated); Conclusions (a brief summary of the essential results you believe were 
demonstrated by the experimental data and the impact of the results). Abstract should be in a form compre-
hensible to any scientist and suitable for publication without the full article text. 
Avoid statements such as "The significance of these results is discussed" that do not help the reader. The ab-
stract should be intelligible to the non-specialist as well as the specialist in your field, and hence should avoid 
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specialized terms and abbreviations. 
ii) Key words. Provide 3-5 key words identifying the nature of the subject matter alphabetically in the last 
part of the summary. 
3. Introduction 
The main part of an article should start with a brief Introduction, which outlines the historical or logical origins of 
the study and clearly states the aim of the study and/or hypothesis to be tested, without repeating the abstract 
or summarizing the results. Avoid giving an extensive review of the literature. 
4. Materials and Methods 
The materials and methods section should provide a sufficient detailed description of the methods to allow a 
researcher to reproduce your work. Companies from which materials were obtained should be listed with their 
location: city and state, province or country. 
The Experimental Procedures or Materials and Methods should give sufficient details to enable the reader to 
repeat your work exactly, if necessary. The necessity for conciseness should not lead to omission of im-
portant experimental details. Refer to previously published procedures employed by citation of both the origi-
nal description and pertinent published modifications, and do not include extensive description unless they pre-
sent substantially new modifications. 
This section should present clearly but succinctly the experimental findings. Only results essential to establish 
the main points of the work should be included. Numerical data should be analyzed using appropriate statistical 
tests. 
For guidelines on how to report statistical results, see Bailar, JC, Mosteller, F (1988) Guidelines for statistical 
reporting in articles for medical journals. Ann Intern Med, 108:266-273; Curran-Everitt, D, Benos DJ, (2004) 
Guidelines for reporting statistics in journals published by the American Physiological Society. J Neurophysiol, 
92:669-671; Lang, TA, Secic, M (2006) How to report statistics in medicine: annotated guidelines for authors, 
editors and reviewers, 2nd edition, Philadelphia, PA, ACP Press; Sarter M, Fritschy JM (2008) Eur J Neurosci 
28:2363-2364. compact presentation. 
Experimental animals: When experimental animals are used, specify species, strain, sex, age, supplier, and 
numbers of animals used in total and for individual experimental conditions. The species should be identified 
in the Title or Abstract. 
Statistical methods: A complete description of statistical methods is required. 
Permissions 
If all or parts of previously published illustrations are used, permission must be obtained from the copyright 
holder concerned. It is the author's responsibility to obtain these in writing and provide copies to the publishers. 
5. Results and Statistical Analyses 
The observations should be presented with minimal reference to earlier literature or to possible interpretations. 
The main statistical results should be reported in the Results section. The description of the statistical results 
should include the proper statistical term (such as the F statistic) as well as the degrees of freedom and the 
P value. The description of statistical results in the figure legends should be limited to important post hoc com-
parisons. 
Statistical methods should be described with enough detail to enable a knowledgeable reader with access to 
the original data to verify the reported results. When possible, findings should be quantified and appropriate 
measures of error or uncertainty (such as confidence intervals) given. Details about eligibility criteria for sub-
jects, randomization and the number of observations should be included. The computer software and the statis-
tical method(s) used should be specified with references to standard works when possible 
6. Discussion 
The discussion section presents the interpretation of the findings, this is the only proper section for subjective 
comments. The discussion section should be as concise as possible and should include a brief statement of the 
principal findings while avoiding repetition of statements provided in the Abstract or the Results section. 
A discussion of the validity of the observations, a discussion of the findings in light of other published work deal-
ing with the same or closely related subjects, and a statement of the possible significance of the work. Exten-
sive discussion of the literature is discouraged. 
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Only published and "in press" (i.e., accepted for publication in a specific journal or book) references should ap-
pear in the reference list at the end of the paper. The latest information on "in press" references should be pro-
vided. Any "in press" references that are relevant for reviewers to see in order to make a well-informed evalua-
tion should be included as a separate document text file along with the submitted manuscript. 
References cited in the text should be numbered in parentheses with Arabic numerals in order of appearance. 
Be sure to verify the wording of any personal communication with the person who supplied the information and 
get his approval for the use of his name in connection with the quoted information. All references should be 
listed in numerical order typed double-spaced on a separate sheet under the heading REFERENCES. 
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1341, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 
Text citations to references written by more than two authors should be styled for example as, Smith et al. In the 
reference list, however, the names of all authors (with initials) must be given. If an article has been accepted for 
publication by a journal but has not yet appeared in print, the reference should be styled as follows: 
29. Tanahashi H and Ito T (1994) Molecular characterization of a novel factor recognizing the interleukin-6 
responsive element. J. Biochem. (in press) 
References should be cited in the text as follows: "The procedure used has been described elsewhere (Green, 
1978),"or "Our observations are in agreement with those of Brown and Black (1979) and of White et al. 
(1980),"or with multiple references, in chronological order: "Earlier reports (Brown and Black, 1979, 1981; White 
etal., 1980; Smith, 1982, 1984)...." 
The use of "in preparation" and "submitted for publication" is not allowed in the reference list. 
Citation of the references written in a language which is usually unreadable for general readers and those pub-
lished in a journal (or book) to which general reader could not easily access should be avoided. 
8. Figure Legends: 
Figure legends must be placed after the Literature Cited section. Manuscript document files lacking figure leg-
ends will not be reviewed. Do not duplicate material from the text or described in the methods in your figure 
legends. Indicate scale bar size if it is not indicated on the figure. Figure legends should be prepared for each 
figure. There should be sufficient experimental detail in the legend to make the figure intelligible without refer-
ence to the text (unless the same material has been given with a previous figure, or in the Experimental Proce-
dures section). 
• Tables: Tables should be self-explanatory and should not duplicate textual material. Each table must be 
appended to the end of the manuscript, after the Figure Legends, in either Word or Excel table format. DO 
NOT embed photographs or image files of tables. Legends or keys must accompany each table and should 
not be added to the Figure Legends. Tables should be numbered consecutively using Arabic numerals, and 
should include a brief title. Use footnotes (superscripted lower-case letters) to explain abbreviations, statis-
tics, etc. Place explanatory matter in footnotes, not in the heading. 
• Figures: Figures must be first cited in the manuscript in ascending numeric order. Subsequent references 
need not be in order, but the first citation of a figure must occur after preceding figures and before following 
figures (eg. Figure 2 cannot be referenced until after Figure 1 has been). Figures can be first referenced in 
groups or in the same figure reference (eg. Figure 1-3 or Figure 5 and 6). 
9. Abbreviations 
Abbreviations should be kept to an absolute minimum. Abbreviations save relatively little space but greatly di-
minish the readability of a manuscript. In general, abbreviations should not appear in the Abstract, and sentenc-
es that contain more than one abbreviation merit careful review. The word must always be written out in full 
when first used and the proposed abbreviation given in parentheses. A list of all abbreviations used in the text 
and their meanings must be provided (in alphabetic order). 
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